Inventor · disambiguated record
Michael Weske
Also filed as: WESKE MICHAEL
20 granted patents·4 pending applications·41 citations·filing 2001–2011
92Inventor score
Files withSOLVAY PHARM GMBH13SOLVAY PHARM BV6ABBOTT HEALTHCARE PRODUCTS BV1ABBOTT PRODUCTS GMBH1DELEERSNIJDER WILLY1
Top patents by PatentIndex Score
24 records- 0182US7238470B2Method of treating or inhibiting obesitySOLVAY PHARM GMBH·Filed 2004·Granted Jul 3, 2007·9 cites·3 claims
- 0282US7189525B2Human enzymes of the metalloprotease familySOLVAY PHARM BV·Filed 2006·Granted Mar 13, 2007·5 cites·3 claims
- 0380US7368582B2Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2004·Granted May 6, 2008·11 cites·11 claims
- 0474US7410962B2Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2007·Granted Aug 12, 2008·2 cites·11 claims
- 0574US6946243B2Method of identifying compounds suitable for treatment and/or prophylaxis of obesitySOLVAY PHARM GMBH·Filed 2001·Granted Sep 20, 2005·4 cites·15 claims
- 0673US8030298B217β-HSD1 and STS inhibitorsABBOTT PRODUCTS GMBH·Filed 2006·Granted Oct 4, 2011·3 cites·23 claims
- 0773US7427611B2Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2006·Granted Sep 23, 2008·2 cites·11 claims
- 0871US7262184B2Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2004·Granted Aug 28, 2007·2 cites·14 claims
- 0969US6855532B2Human enzymes of the metalloprotease familySOLVAY PHARM BV·Filed 2002·Granted Feb 15, 2005·3 cites·22 claims
- 1063US7282325B2Method of preparing pharmaceutical compositionsSOLVAY PHARM GMBH·Filed 2004·Granted Oct 16, 2007·0 cites·2 claims
- 1162US7534903B2Use of amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl-compounds in the treatment of cardiac arrhythmia and other disease statesSOLVAY PHARM GMBH·Filed 2008·Granted May 19, 2009·0 cites·17 claims
- 1260US7312321B2Antibody to human enzymes of the metalloprotease familySOLVAY PHARM BV·Filed 2007·Granted Dec 25, 2007·0 cites·2 claims
- 1360US2008070259A1Novel Human Enzymes of the Metalloprotease FamilySOLVAY PHARM BV·Filed 2007·Application pending·0 cites
- 1458US8273905B2Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivativesMOLONEY BRIAN·Filed 2009·Granted Sep 25, 2012·0 cites·13 claims
- 1557US7714150B2Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivativesSOLVAY PHARM GMBH·Filed 2006·Granted May 11, 2010·0 cites·11 claims
- 1657US7083965B2Human enzymes of the metalloprotease familySOLVAY PHARM BV·Filed 2004·Granted Aug 1, 2006·0 cites·6 claims
- 1753US8012471B2Screening and treatment methods using IGS5 enzymes of the metalloprotease familyABBOTT HEALTHCARE PRODUCTS BV·Filed 2007·Granted Sep 6, 2011·0 cites·6 claims
- 1853US7452875B2Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2007·Granted Nov 18, 2008·0 cites·11 claims
- 1947US8389284B2Screening and treatment methods using IGS5 enzymes of the metalloprotease familyDELEERSNIJDER WILLY·Filed 2011·Granted Mar 5, 2013·0 cites·29 claims
- 2047US2005267124A1Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitorsSOLVAY PHARM GMBH·Filed 2005·Application pending·0 cites
- 2146US2005267072A1Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunctionSOLVAY PHARM GMBH·Filed 2005·Application pending·0 cites
- 2243US2004162345A1Compounds with NEP/MP-inhibitory activity and uses thereofSOLVAY PHARM GMBH·Filed 2003·Application pending·0 cites
- 2342US7232813B2Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disordersSOLVAY PHARM BV·Filed 2005·Granted Jun 19, 2007·0 cites·11 claims
- 2440US8435973B217-beta HSD1 and STS inhibitorsMESSINGER JOSEF·Filed 2010·Granted May 7, 2013·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Michael Weske files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →